Diginex Secures $70 Million in Private Commitments as Resulticks Deal Heads to Shareholder Vote

Diginex gets $70M in private commitments to fund its $1.05B reverse takeover of Resulticks, easing financing doubts ahead of shareholder vote.

The financing puzzle that has hung over Diginex's blockbuster acquisition of Resulticks Global Companies is now solved — at least on paper. The company confirmed Tuesday that private investors have committed a combined $70 million to underwrite the merger, with $20 million earmarked for Diginex directly and $50 million flowing to Resulticks.

The commitments arrive barely a week after Diginex signed the amended and restated purchase agreement for the $1.05 billion reverse takeover, a period in which the stock has shed 3.0 percent. The funding pledge is designed to clear lingering doubts about the transaction's viability ahead of an October 8 shareholder vote on the required capital increases.

A Balance Sheet Built for the Deal

Diginex enters the transaction debt-free, a position that helps explain why investors are backing the merger with equity rather than pushing management toward leveraged financing. The exercise of IPO warrants during the last fiscal year injected $25.4 million into the company, lifting net assets to $20.3 million as of March 31.

Alongside the merger financing, Diginex has unveiled a separate capital raise of $20.0 million, structured as 20 million new common shares paired with 20 million warrants carrying a five-year term and a $1.00 exercise price. While these funds are distinct from the confirmed $70 million in private commitments, they form part of the broader capital envelope supporting the deal.

The company's operating trajectory shows why management considers such an aggressive move necessary. Revenue climbed 77 percent to $3.6 million in fiscal 2026 — respectable growth in percentage terms, but a modest base in absolute numbers. The net loss widened to $31.1 million over the same period, driven by acquisition costs and non-cash charges, underscoring a business that cannot yet carry its own cost structure.

The Dilution Math

The transaction's mechanics are stark. Diginex will issue 600 million new common shares at $1.75 each to fund the acquisition, leaving Resulticks shareholders with roughly 86 percent of the combined entity. Existing Diginex holders will emerge with a sliver of a much larger company — the crux of the dilution debate that has weighed on the share price since the deal was unveiled.

The market's verdict has been unambiguous. The stock closed Friday at $1.28, up 4.1 percent on the day, but the broader trend tells a different story: down 5.3 percent over the past week and 11 to 13 percent over the trailing 30 days, depending on the measurement window. The market capitalization sits at roughly €31 million — a fraction of the transaction's headline value — while annualized volatility of 115 percent on a monthly basis reflects how sensitive the shares remain to each new development.

A Changing of the Guard

The deal also signals a decisive shift in leadership. Chairman Miles Pelham will step down as part of the merger, with Resulticks co-founder and CEO Redickaa Subrammanian slated to lead the combined group. For a transaction formally structured as an acquisition by Diginex, the arrangement is unusually transparent about who will actually run the show — and it is not the incumbent management team.

On the operational front, Diginex has at least demonstrated competence with smaller integrations. The company says the absorption of previously acquired firms Plan A, Matter and The Remedy Project is complete, and the product portfolio has been expanded to include carbon accounting and ESG analytics. Whether that track record translates to a deal that fundamentally restructures the company's own shareholder base remains a far larger test.

Also pending is a new listing application with Nasdaq under Rule 5110 to secure the continued trading of the enlarged entity — a regulatory milestone that can still fail.

For current Diginex shareholders, the choice before them is existential: approve a transaction that will reduce their stake to a fraction of a Resulticks-dominated enterprise, or reject it and leave the company to continue its slow, loss-making climb alone. The secured financing removes the risk of the deal collapsing for lack of capital, but it does nothing to soften the dilution that follows. The share price's recent weakness suggests the market has already priced in that reality — and sees little reason for calm before the October vote.